The overproduction or underproduction of nitric oxide has been implicated i
n pathological symptoms such as endotoxic shock, diabetes, allograft reject
ion, and myocardial ischimia/reperfusion injury. A thorough understanding o
f the biosynthesis of nitric oxide is necessary to probe and manipulate the
se signaling events. There is also considerable pharmacological interest in
developing selective inhibitors of the several isoforms of nitric oxide sy
nthase. The recently determined crystal structures of complexes between nit
ric oxide synthase and substrate, the mechanisms of the enzymatic reaction
that generate nitric oxide and chemical precedents and models for these rea
ctions are now coming into focus, but there are still numerous fascinating
and unanswered questions regarding nitric oxide biosynthesis.